Introduction to the PCR London Valves 2017 Aortic track - The key questions in TAVI: where are we in 2017?

Chairpersons: H. Moellmann, O. Wendler
React@PCR Moderator: T. Patterson

Learning Objectives

  • To appreciate the challenges associated with the further expansion of percutaneous aortic valve intervention
  • To hear the latest evidence addressing the unresolved questions concerning TAVI
  • To understand how to apply this information in your daily clinical practice

Presentations available when logged in:

  • Session objectives and overview of the PCR London Valves 2017 Aortic track
  • Potential pitfalls of TAVI in lower-risk patients
  • Bioprosthetic valve leaflet thickening, subclinical thrombosis and long-term durability
  • Optimal pharmacology - Current evidence and imminent trials
  • TAVI endocarditis - A lurking menace